The role of peroxisome proliferator-activated receptor α in transcriptional regulation of novel organic cation transporters

European Journal of Pharmacology

Volumn 628, Issue 1-3, 2010, Pages 1-5

  Eder, Klaus ^a   Ringseis, Robert ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Carnitine; Novel organic cation transporter; Peroxisome proliferator activated receptor

Indexed keywords

CARNITINE; CELL NUCLEUS RECEPTOR; CLOFIBRATE; FATTY ACID; ORGANIC CATION TRANSPORTER; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PIRINIXIC ACID;

DIET RESTRICTION; DRUG ACTIVITY; FATTY ACID TRANSPORT; HOMEOSTASIS; HUMAN; LIVER; METABOLISM; MITOCHONDRION; MOLECULAR MECHANICS; MUSCLE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REVIEW; RODENT; SMALL INTESTINE; STARVATION; SWINE; TRANSCRIPTION REGULATION; UPREGULATION; WILD TYPE;

ANIMALS; CARNITINE; HUMANS; ORGANIC CATION TRANSPORT PROTEINS; PPAR ALPHA; SPECIES SPECIFICITY; STARVATION; TRANSCRIPTION, GENETIC;

EID: 73649124171     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.11.042     Document Type: Review

References (61)

1. Brandt J.M., Djouadi F., and Kelly D. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor α. J. Biol. Chem. 273 (1998) 23,786-23,792
2. Brass E.P. Pivalate-generating prodrugs and carnitine homeostasis in man. Pharmacol. Rev. 54 (2004) 589-598
3. Brass E.P., and Hoppel C.L. Carnitine metabolism in the fasting rat. J. Biol. Chem. 253 (1978) 2688-2693
4. Chao P.-M., Chao C.-Y., Lin F.-J., and Huang C.-J. Oxidized frying oil up-regulates hepatic acyl-CoA oxidase and cytochrome P450 4A1 genes in rats and activates PPARα. J. Nutr. 131 (2001) 3166-3174
5. Chao P.-M., Hsu S.C., Lin F.-J., Li Y.J., and Huang C.-J. The up-regulation of hepatic acyl-CoA oxidase and cytochrome P450 4A1mRNA expression by dietary oxidized frying oil is comparable between male and female rats. Lipids 39 (2004) 233-238
6. Chao P.-M., Yang M.F., Tseng Y.N., Chang K.M., Lu K.S., and Huang C.J. Peroxisome proliferation in liver of rats fed oxidized frying oil. J. Nutr. Sci. Vitaminol. (Tokyo) 51 (2005) 361-368
7. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 (1999) 648-688
8. Durán J.M., Peral M.J., Calonge M.L., and Ilundáin A.A. OCTN3: a Na+-independent l-carnitine transporter in enterocytes basolateral membrane. J. Cell. Physiol. 202 (2005) 929-935
9. Finck B.N., and Kelly D.P. Peroxisome proliferator-activated receptor α (PPARα) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart. J. Mol. Cell. Cardiol. 34 (2002) 1249-1257
10. Forman B.M., Chen J., and Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4312-4317
11. Grube M., Meyer zu Schwabedissen H.E., Präger D., Haney J., Möritz K.U., Meissner K., Rosskopf D., Eckel L., Böhm M., Jedlitschky G., and Kroemer H.K. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation 113 (2006) 1114-1122
12. Hashimoto T., Cook W.S., Qi C., Yeldandi A.V., Reddy J.K., and Rao M.S. Defect in peroxisome proliferator-activated receptor α-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J. Biol. Chem. 275 (2000) 28,918-28,928
13. Hirano T., Yasuda S., Osaka Y., Kobayashi M., Itagaki S., and Iseki K. Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells. Biochim. Biophys. Acta 1758 (2006) 1743-1750
14. Holden P.R., and Tugwood J.D. Peroxisome proliferator-activated receptor α: role in rodent liver cancer and species differences. J. Mol. Endocrinol. 22 (1999) 1-8
15. Kato Y., Sugiura M., Sugiura T., Wakayama T., Kubo Y., Kobayashi D., Sai Y., Tamai I., Iseki S., and Tsuji A. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse. Mol. Pharmacol. 70 (2006) 829-837
16. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J. Clin. Invest. 103 (1999) 1489-1498
17. Koch A., König B., Luci S., Stangl G.I., and Eder K. Dietary oxidised fat up regulates the expression of organic cation transporters in liver and small intestine and alters carnitine concentrations in liver, muscle and plasma of rats. Br. J. Nutr. 98 (2007) 882-889
18. Koch A., König B., Stangl G.I., and Eder K. PPARα mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis. Exp. Biol. Med. (Maywood) 233 (2008) 356-365
19. Koepsell H., and Endou H. The SLC22 drug transporter family. Pflügers Archiv 447 (2004) 666-676
20. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M.G., and Wahli W. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11 (1997) 779-791
21. Lahjouji K., Mitchell G.A., and Qureshi I.A. Carnitine transport by organic cation transporters and systemic carnitine deficiency. Mol. Gen. Metabol. 73 (2001) 287-297
22. Lahjouji K., Elimrani I., Lafond J., Leduc L., Qureshi I.A., and Mitchell G.A. l-carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2. Am. J. Physiol. Cell Physiol. 287 (2004) C263-C269
23. Lee S.S., and Gonzalez F.J. Targeted disruption of the peroxisome proliferator-activated receptor α gene, PPARα. Ann. N.Y. Acad. Sci. 804 (1996) 524-529
24. Leone T.C., Weinheimer C.J., and Kelly D.P. A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA 96 (1999) 7473-7478
25. Luci S., Geissler S., König B., Koch A., Stangl G.I., Hirche F., and Eder K. PPARα agonists up-regulate organic cation transporters in rat liver cells. Biochem. Biophys. Res. Comm. 350 (2006) 704-708
26. Luci S., Giemsa B., Kluge H., and Eder K. Clofibrate causes an upregulation of PPAR-α target genes but does not alter expression of SREBP target genes in liver and adipose tissue of pigs. Am. J. Physiol. Reg. Integr. Comp. Physiol. 293 (2007) R70-R77
27. Luci S., König B., Giemsa B., Huber S., Hause G., Kluge H., Stangl G.I., and Eder K. Feeding of a deep-fried fat causes PPARalpha activation in the liver of pigs as a non-proliferating species. Br. J. Nutr. 97 (2007) 872-882
28. Luci S., Hirche F., and Eder K. Fasting and caloric restriction increases mRNA concentrations of novel organic cation transporter-2 and carnitine concentrations in rat tissues. Ann. Nutr. Metabol. 52 (2008) 58-67
29. Maeda T., Wakasawa T., Funabashi M., Fukushi A., Fujita M., Motojima K., and Tamai I. Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor α. Biol. Pharm. Bull. 31 (2008) 1230-1236
30. Makowski L., Noland R.C., Koves T.R., Xing W., Ilkayeva O.R., Muehlbauer M.J., Stevens R.D., and Muoio D.M. Metabolic profiling of PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. FASEB J. 23 (2009) 586-604
31. Mandard S., Müller M., and Kersten S. Peroxisome proliferator receptor α target genes. Cell. Mol. Life Sci. 61 (2004) 393-416
32. Mascaro C., Acosta E., Ortiz J.A., Marrero P.F., Hegardt F.G., and Haro D. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J. Biol. Chem. 273 (1998) 8560-8563
33. McGarry J.D., and Brown N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 244 (1997) 1-14
34. McGarry J.D., Robles-Valdes C., and Foster D.W. Role of carnitine in hepatic ketogenesis. Proc. Natl. Acad. Sci. U. S. A. 72 (1975) 4385-4388
35. Ohashi R., Tamai I., Nezu J., Nikaido H., Hashimoto N., Oku A., Sai Y., Shimane M., and Tsuji A. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol. Pharmacol. 59 (2001) 358-366
36. Owen O.E., Morgan A.P., Kemp H.G., Sullivan J.M., Herrera M.G., and Cahill Jr. G.F. Brain metabolism during fasting. J. Clin. Invest. 46 (1967) 1589-1595
37. Paul H.S., and Adibi S.A. Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation. J. Clin. Invest. 64 (1979) 405-412
38. Paul H.S., Gleditsch C.E., and Adibi S.A. Mechanism of increased hepatic concentration of carnitine by clofibrate. Am. J. Physiol. 251 (1986) E311-E315
39. Peters J.M., Cheung C., and Gonzalez F.J. Peroxisome proliferator-activated receptor-α and liver cancer: where do we stand?. J. Mol. Med. 83 (2005) 774-785
40. Qi C., Zhu Y., and Reddy J.K. Peroxisome proliferator-activated receptors, coactivators, and downstream targets. Cell. Biochem. Biophys. 32 (2000) 187-204
41. Rebouche C.J., and Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. Ann. Rev. Nutr. 18 (1998) 39-61
42. Ringseis R., Gutgesell A., Dathe C., Brandsch C., and Eder K. Feeding oxidized fat during pregnancy up-regulates expression of PPARα-responsive genes in the liver of rat fetuses. Lipids Health Dis. 6 (2007) 6
43. Ringseis R., Muschick A., and Eder K. Dietary oxidized fat prevents ethanol-induced triacylglycerol accumulation and increases expression of PPARα target genes in rat liver. J. Nutr. 137 (2007) 77-83
44. Ringseis R., Pösel S., Hirche F., and Eder K. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats. Pharmacol. Res. 56 (2007) 175-183
45. Ringseis R., Luci S., Spielmann J., Kluge H., Fischer M., Geissler S., Wen G., Hirche F., and Eder K. Clofibrate treatment up-regulates novel organic cation transporter (OCTN)-2 in tissues of pigs as a model of non-proliferating species. Eur. J. Pharmacol. 583 (2008) 11-17
46. Ringseis R., Lüdi S., Hirche F., and Eder K. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate increases intestinal carnitine absorption in rats. Pharmacol. Res. 58 (2008) 58-64
47. Ringseis R., Wege N., Wen G., Rauer C., Hirche F., Kluge H., and Eder K. Carnitine synthesis and uptake into cells are stimulated by fasting in pigs as a model of nonproliferating species. J. Nutr. Biochem. 20 (2008) 840-847
48. Schoonjans K., Martin G., Staels B., and Auwerx J. Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr. Opin. Lipidol. 8 (1997) 159-166
49. Schwartz R.S., Holder D.J., Holmes D.R., Veinot J.P., Camrud A.R., Jorgenson M.A., and Johnson R.G. Neointimal thickening after severe coronary artery injury is limited by a short-term administration of a factor Xa inhibitor. Results in a porcine model. Circulation 93 (1996) 1542-1548
50. Sigel B., Swami V., Can A., Parsons R.E., Golub R.M., Kolecki R., and Kitamura H. Intimal hyperplasia producing thrombus organization in an experimental venous thrombosis model. J. Vasc. Surg. 19 (1994) 350-360
51. Spurlock M.E., and Gabler N.K. The development of porcine models of obesity and the metabolic syndrome. J. Nutr. 138 (2008) 397-402
52. Steiber A., Kerner J., and Hoppel C.L. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol. Asp. Med. 25 (2004) 455-473
53. Tamai I., Yabuuchi H., Nezu J., Sai Y., Oku A., Shimane M., and Tsuji A. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 419 (1997) 107-111
54. Tamai I., Ohashi R., Nezu J., Yabuuchi H., Oku A., Shimane M., Sai Y., and Tsuji A. Molecular and functional identification of sodium ion dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 273 (1998) 20,378-20,382
55. Tamai I., Ohashi R., Nezu J.I., Sai Y., Kobayashi D., Oku A., Shimane M., and Tsuji A.I. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J. Biol. Chem. 275 (2000) 40,064-40,072
56. Tan N.S., Michalik L., Desvergne B., and Wahli W. Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes. J. Steroid Biochem. Mol. Biol. 93 (2005) 99-105
57. Tein I. Carnitine transport: pathophysiology and metabolism of known defects. J. Inherit. Metab. Dis. 26 (2003) 147-169
58. van Vlies N., Ferdinandusse S., Turkenburg M., Wanders R.J., and Vaz F.M. PPARα-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. Biochim. Biophys. Acta 1767 (2007) 1134-1142
59. Vaz F.M., and Wanders R.J. Carnitine biosynthesis in mammals. Biochem. J. 361 (2002) 417-429
60. Wen, G., Ringseis, R., Eder, K.: Mouse OCTN2 is directly regulated by peroxisome proliferator-activated receptor α via a PPRE located in the first intron. Biochem. Pharmacol. [Electronic publication ahead of print].
61. Wu X., Huang W., Prasad P.D., Seth P., Rajan D.P., Leibach F.H., Chen J., Conway S.J., and Ganapathy V. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J. Pharmacol. Exp. Ther. 290 (1999) 1482-1492